Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation.

Schernberg, Antoine; Nivet, Alexandre; Dhermain, Frédéric; Ammari, Samy; Escande, Alexandre; Pallud, Johan; Louvel, Guillaume; Deutsch, Eric

Schernberg, Antoine; Nivet, Alexandre; Dhermain, Frédéric; Ammari, Samy; Escande, Alexandre; Pallud, Johan; Louvel, Guillaume; Deutsch, Eric.

Afiliación

Schernberg A; Radiation Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
Nivet A; INSERM1030, Gustave Roussy Cancer Campus, Villejuif, France.
Dhermain F; Radiation Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
Ammari S; Radiation Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
Escande A; Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.
Pallud J; Radiation Oncology Department, Gustave Roussy Cancer Campus, Villejuif, France.
Louvel G; Neurosurgery Department, Sainte-Anne Hospital, Paris, France.
Deutsch E; Paris Descartes University, Sorbonne Paris Cité, Paris, France.

Clin Transl Radiat Oncol ; 10: 47-52, 2018 Mar.

Article en En | MEDLINE | ID: mdl-29928705

Palabras clave

Biomarkers; Concurrent chemoradiation; Glioblastoma; High grade gliomas; Neutrophilia; Prognostic factor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Clin Transl Radiat Oncol Año: 2018 Tipo del documento: Article País de afiliación: Francia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google